Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

Today, 10:07 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

ABSI

1 minute read

BeyondSpring Q2 EPS $(0.49) Misses $(0.48) Estimate

By Bill Haddad

Today, 10:07 AM

BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 6.52 percent decrease over losses of $(0.46) per share from the

BYSI

1 minute read

Earnings Scheduled For September 10, 2021

By Benzinga Insights

Today, 10:07 AM

Companies Reporting Before The Bell • So-Young Intl (NASDAQ:SY) is projected to report quarterly earnings at $0.09 per share on revenue of $67.87 million.

BYSI

1 minute read

Baird Initiates BeyondSpring With Outperform On Plinabulin Potential

By Priya Nigam

Today, 10:07 AM

BeyondSpring Inc’s (NASDAQ: BYSI) lead candidate plinabulin is likely to receive approval around the Nov. 30 PDUFA date for chemotherapy-induced neutropenia (CIN), according to Baird.

BYSI

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 9, 2021

By Benzinga Insights

Today, 10:07 AM

ALGS

2 minute read

News

BeyondSpring Announces Three Poster Presentations About Its Chemotherapy-Induced Neutropenia Prevention Program At The European Society For Medical Oncology 2021 Congress

By Benzinga Newsdesk

Today, 10:07 AM

BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ:BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced three poster presentations of new

BYSI